Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
Justin M. Balko(Vanderbilt University), Rebecca S. Cook(Vanderbilt University), David Vaught(Vanderbilt University), María G. Kuba(Vanderbilt University), Todd W. Miller(Breast Cancer Research Foundation), Neil E. Bhola(Vanderbilt University), Melinda E. Sanders(Vanderbilt University), Nara M Granja-Ingram(Vanderbilt University), J. Joshua Smith(Vanderbilt University), Ingrid M. Meszoely(Breast Cancer Research Foundation), Janine Salter(Institute of Cancer Research), Mitch Dowsett(Institute of Cancer Research), Katherine Stemke‐Hale(The University of Texas MD Anderson Cancer Center), Ana M. González-Angulo(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Joseph A. Pinto(EsSALUD), Henry Gómez(Instituto Nacional de Enfermedades Neoplásicas), Carlos L. Arteaga(Vanderbilt University)
Cited by 261Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis